OTC Valuations delivers complete and independent pricing of derivatives portfolios and focus on the valuation of illiquid, OTC securities and exotic structured products. It also provides vanilla instrument valuation services and comprehensive coverage across the spectrum of instruments traded in the global OTC markets, including fixed income, interest rates, credit, FX, equity, hybrids and structured products.
Clients, which include banks and corporations, custodians, fund administrators and asset managers, elect to receive scheduled independent portfolio valuations and risk reports from OTC Valuations, either as their primary provider, or to complement existing price sources. Other clients include service providers who outsource their complex valuations requirements completely to OTC Valuations who in turn provide white-labelled solutions.
Paul Humphrey, CEO of Tullett Prebon Electronic Broking and Information, said: “Recent market conditions coupled with increasing regulatory oversight have precipitated the growth in demand from fund managers for independent valuation services, notably in the area of complex derivatives. Given Tullett Prebon’s extensive involvement in these markets, both as an inter-dealer broker and as a leading supplier of market data, building a presence in the valuations arena is a natural extension of our risk management services.”
Miroslav Vanous, CEO of OTC Valuations, said: “The scale and global reach that Tullett Prebon brings to our operation will enable us to maintain and expand this core ethic to meet a significant and ongoing increase in customer demand.”
